The genetic architecture of plasma kynurenine includes cardiometabolic disease mechanisms associated with the SH2B3 gene
Abstract Inflammation increases the risk of cardiometabolic disease. Delineating specific inflammatory pathways and biomarkers of their activity could identify the mechanistic underpinnings of the increased risk. Plasma levels of kynurenine, a metabolite involved in inflammation, associates with car...
Guardado en:
Autores principales: | Minoo Bagheri, Chuan Wang, Mingjian Shi, Ali Manouchehri, Katherine T. Murray, Matthew B. Murphy, Christian M. Shaffer, Kritika Singh, Lea K. Davis, Gail P. Jarvik, Ian B. Stanaway, Scott Hebbring, Muredach P. Reilly, Robert E. Gerszten, Thomas J. Wang, Jonathan D. Mosley, Jane F. Ferguson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/82d713fe6c8546188c145b33545e9251 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Kynurenine and depressive symptoms in a poststroke population
por: Bensimon K, et al.
Publicado: (2014) -
Electrochemical Determination of Kynurenine Pathway Metabolites—Challenges and Perspectives
por: Ilona Sadok, et al.
Publicado: (2021) -
Serum profiles of tryptophan-kynurenine pathway metabolites in psoriasis
por: Mariko Seishima, et al.
Publicado: (2021) -
Tryptophan, kynurenine pathway, and diabetic ketoacidosis in type 1 diabetes.
por: William H Hoffman, et al.
Publicado: (2021) -
The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
por: Michelle Broekhuizen, et al.
Publicado: (2021)